Healthcare -
Biotechnology - NASDAQ - CA
$ 3.48
-5.18 %
$ 12.9 M
Market Cap
-0.26
P/E
BCTX - COST OF REVENUE
Cost of Revenue BCTX - BriaCell Therapeutics Corp.
82.6 K
LAST VALUE
133.54%
2 YEAR CAGR
42.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR